Key Development Universal Health Services (UHS) has revised its 2026 earnings outlook downward, citing growing uncertainty over the future of... Read more
Tag: #Global Trends
PHILIP MORRIS’ US$1.2 BILLION U.S. EXPANSION REFLECTS THE ACCELERATING SHIFT TOWARD SMOKE-FREE NICOTINE PRODUCTS
Key Development Philip Morris International (PMI) has doubled its planned investment in its Aurora, Colorado manufacturing campus to approximately US$1.2... Read more
FDA SCRUTINY OF CAPRICOR’S CELL THERAPY UNDERSCORES A NEW BENCHMARK FOR RARE DISEASE INNOVATION
Key Development Capricor Therapeutics is facing a critical regulatory hurdle as U.S. FDA reviewers question whether the clinical evidence supporting... Read more
ASTRAZENECA’S EVOLVING DRUG PRICING STRATEGY SIGNALS A NEW ERA OF GLOBAL PHARMACEUTICAL MARKET NEGOTIATIONS
Key Development AstraZeneca says it is adjusting its pricing strategy for future medicines as the pharmaceutical industry responds to the... Read more
BOSTON SCIENTIFIC’S RESTRUCTURING PLAN REFLECTS A NEW PHASE OF OPERATIONAL DISCIPLINE IN THE MEDTECH INDUSTRY
Key Development Boston Scientific has approved a new company-wide restructuring programme designed to streamline operations, improve cost efficiency, and support... Read more
POTENTIAL WIDESPREAD CYCLOSPORA CONTAMINATION IN CENTRAL MEXICO RAISES NEW QUESTIONS ABOUT GLOBAL FOOD SAFETY OVERSIGHT
Key Development A new assessment from former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb suggests the ongoing cyclosporiasis... Read more
JOHNSON & JOHNSON’S US$5.5 BILLION TALC SETTLEMENT MARKS A PIVOTAL SHIFT IN PHARMACEUTICAL LITIGATION STRATEGY
Key Development Johnson & Johnson has announced a proposed US$5.5 billion settlement to resolve approximately 69,000 remaining lawsuits alleging that... Read more
ASTRAZENECA FACES A NEW TEST OF ITS GROWTH STRATEGY AS RARE DISEASE EXPANSION ENCOUNTERS A CLINICAL SETBACK
Key Development Not every late stage clinical failure changes the trajectory of a pharmaceutical company, but every unsuccessful trial provides... Read more
GERMANY’S SICK LEAVE CRACKDOWN HIGHLIGHTS DEEPER CHALLENGES FOR HEALTHCARE AND WORKFORCE PRODUCTIVITY
Key Development Germany is considering stricter oversight of employee sick leave as rising absenteeism and labour costs fuel concerns among... Read more









